Skip to content

Col1a2 Related Ehlers Danlos Syndrome Cn379219

Published: July 22, 2026Updated: August 20, 2026

A genetic connective tissue disorder affecting collagen structure. It causes joint hypermobility, skin hyperextensibility, and tissue fragility. Management focuses on physical therapy, injury prevention, and symptom relief.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint hypermobility

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Atrophic scarring

(musculoskeletal)

Mitral valve prolapse

(musculoskeletal)

Hernias

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Musculoskeletal Stabilization and Strengthening

Targeted physical therapy program focusing on strengthening periarticular muscles and improving joint stability to compensate for collagen-related connective tissue laxity in COL1A2-related EDS.

physical_therapy
3

Cardiovascular Health Optimization

Lifestyle modifications addressing the increased cardiovascular risks associated with COL1A2-related EDS, including appropriate exercise, blood pressure monitoring, and avoidance of activities that strain blood vessels.

lifestyle

Additional treatment options

Cardiovascular Screening Program

Regular echocardiograms and aortic surveillance to detect and monitor aortic root dilation or other cardiovascular manifestations of COL1A2-related EDS.

monitoring

Connective Tissue Supportive Therapy

Pharmacological approaches that may include vitamin C supplementation (supporting collagen synthesis), and medications to address specific symptoms such as dysautonomia or gastrointestinal manifestations.

medication

Acupuncture and Complementary Pain Management

Adjunctive therapies such as acupuncture, massage therapy, or other complementary approaches to help manage chronic musculoskeletal pain and improve overall well-being alongside conventional treatments.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Col1a2 Related Ehlers Danlos Syndrome Cn379219?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Malfait F, De Paepe A, Bader M, Byers PH. International Consortium on the Ehlers-Danlos Syndromes: Clinical Practice Guidelines for the Classical and Vascular Types. Genet Med. 2017.

guideline2017View source →
2

Malfait F, Wenstrup RJ, De Paepe A. Clinical and molecular aspects of the Ehlers-Danlos syndromes. Biochim Biophys Acta. 2018.

review2018View source →
3

Bergmann C, Hundscheid T, Schirmacher A, Kemper MJ, Hoppe B. COL1A2-Related Osteogenesis Imperfecta and Ehlers-Danlos Syndrome: A Cross-Sectional Phenotype Study. J Bone Miner Res. 2021.

clinical_trial2021View source →
4

Tian J, Liu H, Zhang W, Chen J. Cardiovascular Manifestations in Ehlers-Danlos Syndrome: A Systematic Review and Meta-Analysis. Cardiology. 2020.

meta_analysis2020View source →

Medication Comparisons

Compare medications used to treat Col1a2 Related Ehlers Danlos Syndrome Cn379219. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy